Stay updated on Napabucasin Combo in Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the Napabucasin Combo in Pancreatic Cancer Clinical Trial page.

Latest updates to the Napabucasin Combo in Pancreatic Cancer Clinical Trial page
- Check2 days agoChange DetectedThe footer revision label changed from v3.7.2 to v3.8.0 while the page remains a 403 Forbidden error.SummaryDifference0.2%

- Check9 days agoChange DetectedA site-wide banner appears above the 403 error page, linking to updates and FAQs about NIH’s transition from “Artificial Intelligence” to “Super Intelligence” terminology.SummaryDifference1%

- Check16 days agoChange DetectedThe site footer revision changed from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check23 days agoChange DetectedThe footer revision label changes from v3.7.0 to v3.7.1, with no change to the study information.SummaryDifference0.2%

- Check44 days agoChange DetectedA 403 Forbidden error page is now shown for the study page, replacing the previous detailed study information with a standard error screen and a Home link. This indicates the page is currently inaccessible due to access restrictions.SummaryDifference17%

- Check65 days agoChange DetectedRevision updated from v3.6.5 to v3.6.6, indicating a minor update to the page’s underlying version. This change does not appear to modify the study details or user-facing content.SummaryDifference0.0%

Stay in the know with updates to Napabucasin Combo in Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Napabucasin Combo in Pancreatic Cancer Clinical Trial page.